Cookie Policy

We use cookies on our website and have placed these on your computer. By continuing to use our website you consent to this. For more information, including how to change your cookie settings and to disable our non-essential Google Analytics cookies, please refer to our Cookie Policy. If you do not wish to be reminded of this on each visit, please use the close button.

Kepler Partners LLP

  • Green green grass

    Why the biotech sector is bouncing back to rude health

  • A golden opportunity

    Why the UK small-cap sector looks set to shine

  • Riding the supercycle

    With commodities poised to play a key role in the transition to net zero, BRWM demonstrates the benefit of active management in this sector…

  • Catching the wave

    Why the early bird investors in the UK small-cap sector have historically been well-rewarded…

  • The long and short of it

    FEML’s Polish investments show the attractive potential the trust offers – as well as the managers’ unique approach to markets…

  • A head scratcher

    BBGI’s high yield looks secure but the trust continues to trade at a wide discount...by David Kimberley

  • Bouncing back to rude health

    IBT is well positioned to exploit the attractive valuations on offer in the biotech sector...by Jo Groves

  • Themes for your ISA in 2024

    Kepler Trust Intelligence will be hosting online sessions with fund managers and investors, examining a wide range of strategies and themes to meet the needs of a diversified portfolio

  • Leading the pack

    With a more positive outlook for the biotech sector, IBT has proved its credentials in picking the winners...

  • Canada's time to shine

    MCT's strong dividend growth and prospective rate cuts may result in the trust's discount tightening in the year ahead...

  • No Going back

    AIE's bumper 2023 looks on track to continue into 2024...

11 of 11